InvestSMART

Resonance Health Limited (ASX: RHT) - Announcements

- Current share price for RHT : $0.058

ASX company news and announcements for Resonance Health Limited (RHT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Resonance Health Limited (RHT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Resonance Health Limited (RHT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Resonance Health Limited (RHT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$28 Quarterly Activities/Appendix 4C Cash Flow Report 29 Apr 2025 9:40AM $0.035 $0.058 risen by 65.71%
$28 Change of Director's Interest Notice - Aaron Brinkworth 10 Apr 2025 10:09AM $0.035 $0.058 risen by 65.71%
$28 Half Year Results Presentation 28 Feb 2025 9:40AM $0.060 $0.058 fallen by 3.33%
$28 Half Year Results 28 Feb 2025 9:40AM $0.060 $0.058 fallen by 3.33%
$28 Half Yearly Report and Accounts 28 Feb 2025 9:22AM $0.060 $0.058 fallen by 3.33%
$28 Half Year Results - Call Details 21 Feb 2025 8:17AM $0.055 $0.058 risen by 5.45%
$28 Quarterly Activities/Appendix 4C Cash Flow Report 28 Jan 2025 9:38AM $0.052 $0.058 risen by 11.54%
$28 Receipt of R&D Tax Incentive Refund 24 Jan 2025 10:03AM $0.053 $0.058 risen by 9.43%
$28 Non-deal Investor Roadshow Presentation 2 Dec 2024 8:36AM $0.058 $0.058 fallen by 0%
$28 Results of Annual General Meeting 29 Nov 2024 8:21AM $0.058 $0.058 fallen by 0%
$28 AGM Presentation 28 Nov 2024 12:36PM $0.058 $0.058 fallen by 0%
$28 Resonance Contracted by Major Global Pharma 19 Nov 2024 9:34AM $0.038 $0.058 risen by 52.63%
$28 Trading Halt 18 Nov 2024 9:16AM $0.038 $0.058 risen by 52.63%
$28 Change of Director's Interest Notice - Mitchell Wells 13 Nov 2024 3:08PM $0.038 $0.058 risen by 52.63%
$28 Application for quotation of securities - RHT 12 Nov 2024 10:09AM $0.041 $0.058 risen by 41.46%
$28 Update - Notification of cessation of securities - RHT 11 Nov 2024 8:47AM $0.046 $0.058 risen by 26.09%
$28 Notification regarding unquoted securities - RHT 8 Nov 2024 8:21PM $0.046 $0.058 risen by 26.09%
$28 Notification of cessation of securities - RHT 8 Nov 2024 3:52PM $0.046 $0.058 risen by 26.09%
$28 Notice of Annual General Meeting/Proxy Form 28 Oct 2024 1:21PM $0.054 $0.058 risen by 7.41%
$28 Quarterly Activities/Appendix 4C Cash Flow Report 28 Oct 2024 12:16PM $0.054 $0.058 risen by 7.41%
$28 Date of AGM & Closing Date for Director Nominations 7 Oct 2024 8:18AM $0.060 $0.058 fallen by 3.33%
$28 Full Year Results Presentation 30 Aug 2024 9:34AM $0.062 $0.058 fallen by 6.45%
$28 Full Year Results 30 Aug 2024 9:29AM $0.052 $0.058 risen by 11.54%
$28 Appendix 4E & Annual Report to Shareholders 30 Aug 2024 9:22AM $0.052 $0.058 risen by 11.54%
$28 Appendix 4G & Corporate Governance Statement 30 Aug 2024 9:05AM $0.052 $0.058 risen by 11.54%

51 - 75 of 531 results

Page 3 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.